Improving the Outcome for Children With Cancer: The Costs of Risk Aversion
Dr. Adamson discusses the role of the IGF-1 pathway in cancer and the risks associated with cancer, cancer treatment, and cancer research in children. Presented by Dr. Peter C. Adamson, Professor of Pediatrics & Pharmacology, Children's Hospital of Philadelphia; Chair, Children's Oncology Group. (2016)
This week's Research Roundup covers medicinal cannabis and autism, the use of CRISPR to reduce transplant rejection, gender's role in adolescent food choices and the connection between early cytomegalovirus infection and allergies.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.